UNSPSC 85613121: Supplement accessory pancreatic duct with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement accessory pancreatic duct with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FUF37Z

UNSPSC 85613121 Supplement accessory pancreatic duct with autologous tissue substitute, percutaneous approach is a Commodity code that shows no relevant recent activity in state and local procurement. The six most-recent opportunities posted under or near this code—spanning independent medical evaluation services for pension boards, surgical benefit carve-out programs, occupational medical surveillance, emergency services for detained youth, pharmacy benefit management, and temporary health professional staffing—describe healthcare administration, staffing, and benefits management work that bears no relationship to pancreatic duct surgical procedures or tissue substitutes. The mismatch suggests either a categorical misclassification in the source data or that state and local procurement offices are using this code incorrectly for activities unrelated to its nominal scope.

No state and local procurement opportunities targeting the actual clinical service described by the code—supplementation of an accessory pancreatic duct using autologous tissue in a percutaneous approach—appear in recent postings. The code does not show actionable market activity for business development purposes at this time.